CIM, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CIM, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q4 2022$318,149
+26.8%
9,014
-0.4%
0.06%
+18.9%
Q3 2022$251,000
-14.6%
9,054
+7.6%
0.05%
-13.1%
Q2 2022$294,000
-16.9%
8,416
-1.3%
0.06%
-7.6%
Q1 2022$354,000
-21.2%
8,525
-27.5%
0.07%
-21.4%
Q4 2021$449,000
+2.7%
11,758
+2.6%
0.08%
+23.5%
Q3 2021$437,000
+11.5%
11,464
+6.2%
0.07%
+6.2%
Q2 2021$392,000
+50.2%
10,796
+15.8%
0.06%
+36.2%
Q1 2021$261,000
+21.4%
9,321
+4.9%
0.05%
+17.5%
Q4 2020$215,0008,8850.04%
Other shareholders
IRADIMED CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders